ロード中...
Effectiveness and safety of Triac in children and adults with MCT8 deficiency: an international, multicentre, single group, open-label, phase 2 trial
BACKGROUND: Deficiency of the thyroid hormone transporter MCT8 causes severe intellectual and motor disability and high serum T3 concentrations. Chronic thyrotoxicosis leads to progressive deterioration in body weight, tachycardia and muscle wasting, predisposing to significant morbidity and mortali...
保存先:
| 出版年: | Lancet Diabetes Endocrinol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7611958/ https://ncbi.nlm.nih.gov/pubmed/31377265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-8587(19)30155-X |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|